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ABSTRACTS0525: AUGIS TRAINEE PRIZE WINNER: ANTIMICROBIAL PROPHYLAXIS
PRIOR TO PANCREATICO-DUODENECTOMY
Peter Thomson, Miruna David, Simon Bramhall, John Isaac,
Ravi Marudanayagam, Darius Mirza, Paolo Muiesan, Robert Sutcliffe.
Queen Elizabeth Hospital, Birmingham, UK.
Aim: At our unit, antimicrobial prophylaxis prior to pancreatico-duode-
nectomy (PD) consists of tazocin/ﬂuconazole in patients who had preop-
erative biliary drainage (PBD), or co-amoxiclav in patients without PBD.
The objective of this study was to determine the appropriateness of these
regimens by analysis of intraoperative bile samples.
Methods: Retrospective analysis of 60 consecutive patients who under-
went PD (May 2011 - April 2012). Data regarding intraoperative bile cul-
tures/sensitivities were recorded.
Results: Intraoperative bile samples were available in 33/36 patients who
underwent PBD, and were positive in 30 (91%): bacteria in 26 (single 13,
multiple 13) and fungi in 18. Bile samples were available in 16/24 patients
in the non-PBD group, of which 5 were positive (31%) for bacterial infec-
tion (single in all cases). In the PBD group, bacterial sensitivities were co-
amoxiclav 12/26, tazocin 20/26, meropenem+vancomycin 25/26 and cip-
roﬂoxacin/gentamicin+metronidazole 16/26. In the non-PBD group, sen-
sitivities were co-amoxiclav 3/5, tazocin 5/5, meropenem+vancomycin 5/5
and ciproﬂoxacin/gentamicin+metronidazole 4/5. Surgical site infections
occurred in 8% of the PBD group and 29% of the non-PBD group.
Conclusions: Anti-fungal prophylaxis is essential prior to pancreatico-
duodenectomy in patients who have undergone preoperative biliary
drainage. Regular review of intraoperative bile cultures and tailoring of
prophylactic antibiotic regimens is recommended.
0531: ROLE OF ENDOSCOPIC ULTRASOUND AND MULTIDIMENSIONAL
COMPTUED TOMOGRAPHY IN PREDICTING NEED FOR MESENTERIC
VEIN RESECTION IN PANCREATICODUODENECTOMY SPECIMENS e A
HISTOPATHOLOGICAL CORRELATION
Ronan Kelly, Tom Gallagher, Kevin Conlon, Emir Hoti, Donal Maguire,
Justin Geoghegan, Oscar Traynor. National Surgical Centre for Pancreatic
Cancer, St Vincent's University Hospital, Dublin, Ireland.
In locally advanced pancreatic cancer, portal vein resection has been
shown to be a safe and feasible procedure that increases the number of
patients who undergo curative resection with a survival beneﬁt.
A retrospective review of a prospectively maintained database of pan-
creaticoduodenectomy operations performed at National Surgical Centre
for Pancreatic Cancer over 36 months (2010-2012) was performed. We
looked at the pre-operative prediction of the need for venous resection
made at the time of multidisciplinary team evaluation of CT and EUS
ﬁndings based on current NCCN ‘borderline resectable’ criteria for venous
involvement.
Portal vein resection, with primary repair or reconstruction, was per-
formed in 20 of 218(9%) consecutive procedures. Diagnostic pre-operative
4-Phase CT-Pancreas had been performed in all cases where vein resection
was performed while additional EUS was performed in 15/20(75%).
Combined preoperative imaging predicted the need for resection in 10 of
20(50%) cases while CT alone predicted only 6/20(30%). The R0 resection
rate was 12/20(60%) with 17(85%) patients alive at follow-up.
Despite advances in multi-planar imaging, preoperative radiological
evaluation often underestimates the need for mesenteric vein resection.
All patients undergoing surgical resection for pancreatic cancer should be
consented and assessed for suitability to undergo major venous resection
and reconstruction.
0598: BASOwTHE ASSOCIATION OF CANCER SURGERY PRIZE WINNER:
DETERMINING COMPLETE CLINICAL RESPONSE OF RADIOLOGICALLY
DISAPPEARING COLORECTAL LIVER METASTASES AFTER CHEMO-
THERAPY AND HOW THEY SHOULD BE MANAGED
David Hunter 1, Ashish Shrestha 1, Duncan Spalding 2, Madhava Pai 2.
1 Imperial College, London, UK; 2Hammersmith Hospital, London, UK.
Aim: To determine if radiologically disappearing liver metastases (DLMs)
after chemotherapy correspond to a complete clinical response. The
treatment of DLMs was also assessed to determine whether they should be
resected or left insitu.
Methods: A retrospective review was carried out on 342 patients referred
for surgical opinion between January 2001 and January 2012. Twenty-eight patients showed evidence of at least one metastasis disappearing
radiologically after chemotherapy. 16 patients were subsequently eligible
for review, median follow up of 27.6 months (range 5.2 e 113.9 months).
Results: 35 metastases were identiﬁed in 16 patients. Twenty-eight me-
tastases disappeared on imaging. 10 patients had 15 DLMs left insitu and 6
patients had 13 DLMs resected. Complete clinical responsewas observed in
15 DLMs (53.6%) on follow up. Five showed no recurrence within one year
in those left insitu (33.3%) and 10 showed complete pathological response
after resection (76.9%). A signiﬁcantly reduced recurrence free survival was
observed in the insitu group, [6.3 vs 19.4 months (p<0.001)], but overall
survival was not signiﬁcantly different between the two groups (p¼0.12).
Conclusion: DLMs radiologically do not necessarily confer a complete
clinical response. They should be resected when possible but leaving them
insitu can be warranted.
0826: IS NORMAL MACROSCOPIC APPEARANCE OF THE GALLBLADDER
FOLLOWING CHOLECYSTECTOMY SUFFICIENT TO EXCLUDE
MALIGNANCY?
Christopher Emmett 1,2, Andrew Gilliam 1,2, Andrew Mitchell 1,2,
Paul Barrett 1,2. 1Darlington Memorial Hospital, County Durham, UK;
2University Hospital of North Durham, County Durham, UK.
Aims: Occasionally, histological examination of the gallbladder following
routine cholecystectomy reveals an incidental cancer. We aim to assess
whether inspection of the gallbladder postoperatively, followed by histo-
logical examination of macroscopically abnormal specimens only, could be
a safe and cost-effective alternative to routine histological examination in
every case.
Methods: Patients undergoing emergency or elective cholecystectomy
between 1 May 2003 and 1 September 2010 were included. Pathology
records were used to identify all gallbladder malignancies. Only gall-
bladder cancers picked up incidentally following cholecystectomy were
included. Pathology reports were reviewed to establish whether there was
a macroscopic abnormality.
Results: 4776 patients were identiﬁed, including 532 emergencies. Overall
median age was 54 years (range 14 e 95), Male:Female ¼ 1:3. Of these,
13(0.27%) were found to have cancer; these patents had amedian age of 68
years (range 48-84). 42% of cancer cases were emergency admissions (5
patients, data incomplete for one case) compared with 11% of benign cases
(527 patients) (P¼0.0068). Of the cancer cases, 5 gallbladder specimens
(38%) had no documented macroscopic abnormality.
Conclusions: Most cancers are suspected from macroscopic appearance
but a small number are not, and these may be missed. Emergency cases
and older patients are particularly at risk.
0846: PRE-OPERATIVE LIVER ENZYME PREDICTS SURVIVAL AND
RECURRENCE AFTER LIVER RESECTION FOR HEPATOCELLULAR CARCI-
NOMA ARISING FROM NON-CIRRHOTIC/NON-FIBROTIC LIVER: A EURO-
PEAN PERSPECTIVE
C.Y. Tan 2, V.S. Yip 1, G. Sarno 1, S. Staettner 1, M. Terlizzo 1, N. Misra 1,
S. Fenwick 1, H. Malik 1, P. Ghaneh 1, G. Poston 1. 1Department of
Hepatobiliary Surgery and Cellular Pathology, Aintree University Hospital,
Liverpool, UK; 2 School of Medicine, University of Liverpool, Liverpool, UK.
Background: HCC is uncommon in western countries. This study evalu-
ated outcomes and prognostic factors following hepatectomy for HCC
arising in non-cirrhotic/non-ﬁbrotic livers.
Methods: Over a 15-year period, patients undergoing hepatectomy for
HCC were identiﬁed from prospectively maintained database. Patient de-
mographics, pre-operative biochemical and hematological factors, intra-
and postoperative clinical details, and tumour pathology were analysed
against overall (OS) and disease progression-free (PFS) survival.
Results: 57 patients underwent hepatectomy for non-cirrhotic/non-
ﬁbrotic HCC during study period. Median PFS was 22 months and me-
dian OS was 37 months, with 3- and 5-year survival rates post-resection
of 48% and 39% respectively. 42% developed recurrent disease. In uni-
variate analysis, the liver enzyme ratio was a factor affecting both OS and
PFS (p¼0.002). There was a signiﬁcant trend towards poorer OS (Log
rank test, p¼0.04) for patients with poorly differentiated tumours
compared to well and moderately differentiated tumours. Using Cox
proportional hazard model analysis, pre-operative liver enzyme ratio
was an indenpendent factor for both OS(HR¼3.13, p<0.02) and
PFS(HR¼1.02, p¼0.04) post-hepatectomy. Poorly differentiated tumour
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ABSTRACTSwas also a prognostic indicator for the OS (HR¼2.48, p¼0.035) in HCC
after resection.
Conclusions: Liver function prior to surgery and poor tumour differenti-
ation are prognostic factors for OS and PFS after resection.
0871: LAPAROSCOPIC SUBTOTAL CHOLECYSTECTOMY WITHOUT CYSTIC
DUCT LIGATION e AN ALTERNATIVE TO OPEN CONVERSION. A PRO-
SPECTIVE STUDY
Pavan Padaki 1, Himanshu Wadhawan 1, Sanjay Pandanaboyana 2,
Afshin Alijani 1. 1NHS Tayside, Dundee, UK; 2Royal Inﬁrmary of Edinburgh,
Edinburgh, UK.
Introduction: Laparoscopic cholecystectomy is the gold standard in the
treatment of symptomatic gallstones. The dissection of the calot's triangle
can be complicated by acute or chronic inﬂammation. Laparoscopic sub-
total cholecystectomy can be an alternative to open conversion for these
difﬁcult cases.
Methods: Prospective study of laparoscopic subtotal cholecystectomies
performed by a single surgeon in a teaching hospital from 2007 - 2011.
Total 179 cholecystectomies were performed, 162 were laparoscopic, 6
were open conversions, 1 open and 10 laparoscopic subtotal. 104 were
elective and 58 were emergency.
Results: Ten laparoscopic subtotal cholecystectomies without cystic duct
ligation were performed. Median age was 65 years (range 52-84 years).
Median duration of hospital stay was 7 days (range 7-40 days). 7 were
emergency and 3were elective. Operative ﬁndings included empyema in 4,
chronic cholecystitis in 2, acute in 3 and perforated gall bladder in 1. All
patients had an intra-abdominal drain placement. Bile leak occurred in
two patients, one settled spontaneously in 8 days and the other was
managed with an endoscopic retrograde cholangiopancreatography and
stent. No other complications were reported.
Conclusion: Laparoscopic subtotal cholecystectomy is an alternative to
open conversion in difﬁcult cases. Bile leak can occur but can be easily
managed.
0983: ROUTINE COAGULATION SCREENING IS AN UNNECESSARY STEP IN
PATIENTS WITHOUT EVIDENCE OF BIOCHEMICAL JAUNDICE PRIOR TO
ERCP
Jonathan Nicholls, Richard Egan, Michael Stechman. University Hospital of
Wales, Cardiff, UK.
Aims: UK guidelines recommend that patients undergoing endoscopic
retrograde cholangio-pancreatography (ERCP) should undergo coagulation
screening within 72 hours of the procedure. We hypothesised that coag-
ulation is rarely deranged without biochemical jaundice, making coagu-
lation screening unnecessary.
Methods: All ERCP procedures performed at our tertiary referral centre
between June 2011 and September 2012 were analysed. Demographics, pre-
procedure prothrombin time (PT), bilirubin levels, indications and pro-
cedures performed were recorded. 519 procedures were included, with 55
patients excluded due to incomplete records or anti-coagulation therapy.
Results: The cohort was divided into two groups: jaundiced (n¼266)
(elevated pre-procedure bilirubin) and non-jaundiced (n¼253) (normal
pre-procedure bilirubin). In the jaundiced group 6% had a signiﬁcantly
prolonged PT (international normalised ratio (INR) of1.5). In the non-
jaundiced group none had an INR1.5, 6% had a mildly raised PT
(INR¼1<x<1.5), with no bleeding complications. The PT between the
jaundiced and non-jaundiced groups was signiﬁcantly different (mean
conﬁdence interval; 12.90.65 vs. 11.10.14; p<0.001).
Conclusions: Our data suggests that patients with normal bilirubin levels
pre-ERCP rarely have deranged coagulation. In patients with a negative
bleeding history and normal liver function tests undergoing ERCP, we
suggest that coagulation screening is unnecessary. Focused coagulation
testing could represent an annual saving of over £370,000 nationally.
1034: COMMON BILE DUCT e DOES SIZE MATTER?
Anna Kamocka 1, Lisa Bradley 2, Nigel D'Souza 1, Andrew Gordon 1.
1Heatherwood and Wexham Park Hospitals NHS Foundation Trust, Slough,
Berkshire, UK; 2Ashford and St Peter's Hospitals NHS Trust, Chertsey, Surrey, UK.
Aims: To evaluate correlation between pre- and intraoperative common
bile duct (CBD) measurements and incidence of CBD stones at the routine
intraoperative cholangiogram(IOC).Methods: Retrospective review of patients undergoing laparoscopic cho-
lecystectomy with routine IOC at Wexham Park Hospital between Jan
2007-Jan 2010. CBD size at pre-operative imaging (USS, CT and/or MRCP)
and IOC were analysed alongside with incidence of CBD calculi.
Results: 78 patients underwent IOC. In 21(Group 1), CBD size was measured
preoperatively at 4-15mm(mean 8mm) whereas intraoperative CBD size
ranged between 6-23mm(mean 11mm). CBD calculi were seen in 7 cases
preoperatively. 1 patient whose CBD measured 6mm preoperatively had a
6mm stone present at IOC. 2 patients with CBD of 11mm and 14mm preop-
eratively had intraoperative CBDof 20 and 18mmrespectivelywith no calculi.
In 57 patients (Group 2), preoperative CBD was reported as normal on USS
but the size was not speciﬁed. On IOC, CBD size was 3-14mm(mean
6.8mm)with abnormalities not detected on pre-operative USS in 4 cases (1
CBD stone, 1 stricture, no ﬂow to duodenum in 2 cases).
Conclusions: There is poor correlation between CBD size measured pre-
and intraoperatively. It is difﬁcult to predict presence of CBD calculi at the
time of operation based on pre-operative imaging.1214: TIMING OF CHOLECYSTECTOMY FOLLOWING ACUTE ADMISSION
WITH CHOLELITHIASIS
Lewis Taylor, Andrew Torrance. Heart of England Foundation Trust,
Birmingham, UK.
Aim: There is increasing evidence supporting early over delayed
cholecystectomy for acute cholelithiasis. This study aims to identify factors
that could predict those who may beneﬁt from early cholecystectomy.
Method: A retrospective review of a prospectively maintained database of
emergency surgical admissions at a single centre was undertaken. Ad-
missions for acute cholelithiasis were identiﬁed over 6 months and fol-
lowed-up for 6 months. Data on patient demographics, admission details,
investigations, interventions and re-admissions were collected.
Results: 82 patients were identiﬁed (24(29.3%) male, median age 56(range
18-91)). 46(56.1%) patients had biliary colic, 33(40.2%) cholecystitis and
3(3.7%) cholangitis. 60(73%) patients had a cholecystectomy; 37(62%) on a
separate planned admission, 20(33%) during index admission, 3(5%) at a
subsequent emergency admission. No signiﬁcant difference in post-oper-
ative complications was seen between the groups. 19(23%) patients were
re-admitted with acute cholelithiasis within 6 months. There were no re-
admissions following cholecystectomy at index admission (p¼0.004).
Multiple logistic regression demonstrated no statistically signiﬁcant ef-
fects on the rate of in-patient cholecystectomy or re-admission when
adjusted for age, gender, sepsis, deranged liver function tests, in-
vestigations or cholecystitis. (Chi square¼15.6614;df¼9;p¼0.0743 and Chi
square¼8.6635;df¼8;p¼0.3715 respectively).
Conclusion: Early cholecystectomy for cholelithiasis is safe, effective and
signiﬁcant reduces the rate of re-admission with biliary complaints.1219: RADIOFREQUENCY ABLATION FOR COLORECTAL LIVER METASTA-
SES e A META-ANALYSIS
Christodoulos Neophytou, Antonis Valahis. Nottingham City Hospital,
Nottingham, UK.
Aims: The aim of themeta-analysis is to evaluate the comparative therapeutic
efﬁcacyof radiofrequencyablation (RFA)andhepatic resection (HR) for solitary
colorectal livermetastases (CLM)andtestwhetherRFA is superiorcomparedto
HR when it comes to survival (overall and disease free) and recurrence.
Methods: All studies citing the MeSH terms, ‘'ablation'' and ‘‘colorectal
liver metastasis'' were identiﬁed by searching the Medline database be-
tween March 2006 and March 2012. The outcome measures were the HRs
and 95% CIs for the disease free survival and overall survival as well as the
follow up period.
Results: From the 8 eligible studies overall survival and disease free sur-
vival are in favor of HR and this is statistically signiﬁcant (p-value¼ 0.0002
and <0.001 respectively). The risk of recurrence following RFA is 3.54
times greater compared to the one following hepatic resection.
Conclusions: Liver resection remains the best treatment option for solitary
resectable CLM - it is associated with acceptable morbidity providing
adequate patient selection. In contrast, RFA is associated with signiﬁcant
risk of local recurrence which generally translates into decreased survival
compared to resection. Currently, RFA cannot be considered a valuable
alternative to liver resection in case of resectable CLM.
